APO Research
Talk to an analyst

APO RESEARCH · REPORT

Pharmaceutical API and Intermediates

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Pharmaceutical API and Intermediates Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

22 December 2025198 pages

Choose your research edition.

Industry ResearchPharmaceutical API and Intermediates Industry Research Report 2026142 pages · $2,950 USDIndustry Growth & TrendsGlobal Pharmaceutical API and Intermediates Industry Growth and Trends Forecast to 2032121 pages · $3,450 USDMarket StructureGlobal Pharmaceutical API and Intermediates Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pharmaceutical API and Intermediates Market Outlook and Growth Opportunities 2026218 pages · $4,250 USDMarket Analysis & ForecastGlobal Pharmaceutical API and Intermediates Market Analysis and Forecast 2026-2032210 pages · $4,950 USD

Market perspective

The global Pharmaceutical API and Intermediates market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Pharmaceutical API and Intermediates is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Pharmaceutical API and Intermediates is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Pharmaceutical API and Intermediates is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Pharmaceutical API and Intermediates is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Pharmaceutical API and Intermediates include Lonza, BASF, Patheon, Lianhetech, Jubilant, Catalent, ABA Chem, Actylis and Chiracon, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

On the production side, the report examines Pharmaceutical API and Intermediates output, growth rates, and market shares by manufacturer and by region (at regional and country level) for 2021-2026, with forecasts through 2032.

On the consumption side, the report analyzes sales of Pharmaceutical API and Intermediates by region (regional and country level), company, type, and application for 2021-2026 and provides forecasts through 2032.

The report provides an overview of the global Pharmaceutical API and Intermediates market in terms of capacity, output, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Pharmaceutical API and Intermediates and consumption patterns in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Pharmaceutical API and Intermediates sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by type and application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Pharmaceutical API and Intermediates market size, projected growth trends, production technologies, key applications, and end-use industries.

Pharmaceutical API and Intermediates Segment by Company

Lonza

BASF

Patheon

Lianhetech

Jubilant

Catalent

ABA Chem

Actylis

Chiracon

Codexis

CordenPharma

Granules India

Pfizer

Porton

Sanofi

Jiuzhou Pharmaceutical

Menohua

Puluo Pharmaceutical

Stanley

Tianyu shares

Huahai Pharmaceutical

Pharmaceutical API and Intermediates Segment by Type

API

Pharmaceutical Intermediates

Pharmaceutical API and Intermediates Segment by Application

Pharmaceutical

Feed

Food

Cosmetics

Health Products

Pharmaceutical API and Intermediates Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pharmaceutical API and Intermediates market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pharmaceutical API and Intermediates and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pharmaceutical API and Intermediates.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Pharmaceutical API and Intermediates market, including product definition, global market growth prospects, production value, capacity, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Pharmaceutical API and Intermediates industry.

Chapter 3: Detailed analysis of Pharmaceutical API and Intermediates market competition landscape. Including Pharmaceutical API and Intermediates manufacturers' output value, output and average price from 2021 to 2026, as well as competition analysis indicators such as origin, product type, application, merger and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 7: Production/Production Value of Pharmaceutical API and Intermediates by region. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 8: Consumption of Pharmaceutical API and Intermediates in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Pharmaceutical API and Intermediates Industry Trends Table 2. Pharmaceutical API and Intermediates Industry Drivers Table 3. Pharmaceutical API and Intermediates Industry Opportunities and Challenges Table 4. Pharmaceutical API and Intermediates Industry Restraints Table 5. Global Pharmaceutical API and Intermediates Production Value by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Pharmaceutical API and Intermediates Production Value Share by Manufacturers (2021-2026) Table 7. Global Pharmaceutical API and Intermediates Production by Manufacturers (Tons) & (2021-2026) Table 8. Global Pharmaceutical API and Intermediates Production Market Share by Manufacturers Table 9. Global Pharmaceutical API and Intermediates Average Price (US$/Ton) of Manufacturers (2021-2026) Table 10. Global Pharmaceutical API and Intermediates Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Pharmaceutical API and Intermediates Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Pharmaceutical API and Intermediates Manufacturers, Product Type & Application Table 13. Global Pharmaceutical API and Intermediates Manufacturers Established Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Pharmaceutical API and Intermediates by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Production Value of 2025) Table 16. Major Manufacturers of API Table 17. Major Manufacturers of Pharmaceutical Intermediates Table 18. Global Pharmaceutical API and Intermediates Production by Type 2021 VS 2025 VS 2032 (Tons) Table 19. Global Pharmaceutical API and Intermediates Production by Type (2021-2026) & (Tons) Table 20. Global Pharmaceutical API and Intermediates Production by Type (2027-2032) & (Tons) Table 21. Global Pharmaceutical API and Intermediates Production Market Share by Type (2021-2026) Table 22. Global Pharmaceutical API and Intermediates Production Market Share by Type (2027-2032) Table 23. Global Pharmaceutical API and Intermediates Production Value by Type 2021 VS 2025 VS 2032 (Tons) Table 24. Global Pharmaceutical API and Intermediates Production Value by Type (2021-2026) & (Tons) Table 25. Global Pharmaceutical API and Intermediates Production Value by Type (2027-2032) & (Tons) Table 26. Global Pharmaceutical API and Intermediates Production Value Market Share by Type (2021-2026) Table 27. Global Pharmaceutical API and Intermediates Production Value Market Share by Type (2027-2032) Table 28. Major Manufacturers of Pharmaceutical Table 29. Major Manufacturers of Feed Table 30. Major Manufacturers of Food Table 31. Major Manufacturers of Cosmetics Table 32. Major Manufacturers of Health Products Table 33. Global Pharmaceutical API and Intermediates Production by Application 2021 VS 2025 VS 2032 (Tons) Table 34. Global Pharmaceutical API and Intermediates Production by Application (2021-2026) & (Tons) Table 35. Global Pharmaceutical API and Intermediates Production by Application (2027-2032) & (Tons) Table 36. Global Pharmaceutical API and Intermediates Production Market Share by Application (2021-2026) Table 37. Global Pharmaceutical API and Intermediates Production Market Share by Application (2027-2032) Table 38. Global Pharmaceutical API and Intermediates Production Value by Application 2021 VS 2025 VS 2032 (Tons) Table 39. Global Pharmaceutical API and Intermediates Production Value by Application (2021-2026) & (Tons) Table 40. Global Pharmaceutical API and Intermediates Production Value by Application (2027-2032) & (Tons) Table 41. Global Pharmaceutical API and Intermediates Production Value Market Share by Application (2021-2026) Table 42. Global Pharmaceutical API and Intermediates Production Value Market Share by Application (2027-2032) Table 43. Lonza Company Information Table 44. Lonza Business Overview Table 45. Lonza Pharmaceutical API and Intermediates Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 46. Lonza Pharmaceutical API and Intermediates Product Portfolio Table 47. Lonza Recent Development Table 48. BASF Company Information Table 49. BASF Business Overview Table 50. BASF Pharmaceutical API and Intermediates Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 51. BASF Pharmaceutical API and Intermediates Product Portfolio Table 52. BASF Recent Development Table 53. Patheon Company Information Table 54. Patheon Business Overview Table 55. Patheon Pharmaceutical API and Intermediates Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 56. Patheon Pharmaceutical API and Intermediates Product Portfolio Table 57. Patheon Recent Development Table 58. Lianhetech Company Information Table 59. Lianhetech Business Overview Table 60. Lianhetech Pharmaceutical API and Intermediates Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 61. Lianhetech Pharmaceutical API and Intermediates Product Portfolio Table 62. Lianhetech Recent Development Table 63. Jubilant Company Information Table 64. Jubilant Business Overview Table 65. Jubilant Pharmaceutical API and Intermediates Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 66. Jubilant Pharmaceutical API and Intermediates Product Portfolio Table 67. Jubilant Recent Development Table 68. Catalent Company Information Table 69. Catalent Business Overview Table 70. Catalent Pharmaceutical API and Intermediates Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 71. Catalent Pharmaceutical API and Intermediates Product Portfolio Table 72. Catalent Recent Development Table 73. ABA Chem Company Information Table 74. ABA Chem Business Overview Table 75. ABA Chem Pharmaceutical API and Intermediates Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 76. ABA Chem Pharmaceutical API and Intermediates Product Portfolio Table 77. ABA Chem Recent Development Table 78. Actylis Company Information Table 79. Actylis Business Overview Table 80. Actylis Pharmaceutical API and Intermediates Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 81. Actylis Pharmaceutical API and Intermediates Product Portfolio Table 82. Actylis Recent Development Table 83. Chiracon Company Information Table 84. Chiracon Business Overview Table 85. Chiracon Pharmaceutical API and Intermediates Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 86. Chiracon Pharmaceutical API and Intermediates Product Portfolio Table 87. Chiracon Recent Development Table 88. Codexis Company Information Table 89. Codexis Business Overview Table 90. Codexis Pharmaceutical API and Intermediates Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 91. Codexis Pharmaceutical API and Intermediates Product Portfolio Table 92. Codexis Recent Development Table 93. CordenPharma Company Information Table 94. CordenPharma Business Overview Table 95. CordenPharma Pharmaceutical API and Intermediates Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 96. CordenPharma Pharmaceutical API and Intermediates Product Portfolio Table 97. CordenPharma Recent Development Table 98. Granules India Company Information Table 99. Granules India Business Overview Table 100. Granules India Pharmaceutical API and Intermediates Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 101. Granules India Pharmaceutical API and Intermediates Product Portfolio Table 102. Granules India Recent Development Table 103. Pfizer Company Information Table 104. Pfizer Business Overview Table 105. Pfizer Pharmaceutical API and Intermediates Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 106. Pfizer Pharmaceutical API and Intermediates Product Portfolio Table 107. Pfizer Recent Development Table 108. Porton Company Information Table 109. Porton Business Overview Table 110. Porton Pharmaceutical API and Intermediates Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 111. Porton Pharmaceutical API and Intermediates Product Portfolio Table 112. Porton Recent Development Table 113. Sanofi Company Information Table 114. Sanofi Business Overview Table 115. Sanofi Pharmaceutical API and Intermediates Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 116. Sanofi Pharmaceutical API and Intermediates Product Portfolio Table 117. Sanofi Recent Development Table 118. Jiuzhou Pharmaceutical Company Information Table 119. Jiuzhou Pharmaceutical Business Overview Table 120. Jiuzhou Pharmaceutical Pharmaceutical API and Intermediates Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 121. Jiuzhou Pharmaceutical Pharmaceutical API and Intermediates Product Portfolio Table 122. Jiuzhou Pharmaceutical Recent Development Table 123. Menohua Company Information Table 124. Menohua Business Overview Table 125. Menohua Pharmaceutical API and Intermediates Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 126. Menohua Pharmaceutical API and Intermediates Product Portfolio Table 127. Menohua Recent Development Table 128. Puluo Pharmaceutical Company Information Table 129. Puluo Pharmaceutical Business Overview Table 130. Puluo Pharmaceutical Pharmaceutical API and Intermediates Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 131. Puluo Pharmaceutical Pharmaceutical API and Intermediates Product Portfolio Table 132. Puluo Pharmaceutical Recent Development Table 133. Stanley Company Information Table 134. Stanley Business Overview Table 135. Stanley Pharmaceutical API and Intermediates Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 136. Stanley Pharmaceutical API and Intermediates Product Portfolio Table 137. Stanley Recent Development Table 138. Tianyu shares Company Information Table 139. Tianyu shares Business Overview Table 140. Tianyu shares Pharmaceutical API and Intermediates Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 141. Tianyu shares Pharmaceutical API and Intermediates Product Portfolio Table 142. Tianyu shares Recent Development Table 143. Huahai Pharmaceutical Company Information Table 144. Huahai Pharmaceutical Business Overview Table 145. Huahai Pharmaceutical Pharmaceutical API and Intermediates Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 146. Huahai Pharmaceutical Pharmaceutical API and Intermediates Product Portfolio Table 147. Huahai Pharmaceutical Recent Development Table 148. Global Pharmaceutical API and Intermediates Production by Region: 2021 VS 2025 VS 2032 (Tons) Table 149. Global Pharmaceutical API and Intermediates Production by Region (2021-2026) & (Tons) Table 150. Global Pharmaceutical API and Intermediates Production Market Share by Region (2021-2026) Table 151. Global Pharmaceutical API and Intermediates Production Forecast by Region (2027-2032) & (Tons) Table 152. Global Pharmaceutical API and Intermediates Production Market Share Forecast by Region (2027-2032) Table 153. Global Pharmaceutical API and Intermediates Production Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 154. Global Pharmaceutical API and Intermediates Production Value by Region (2021-2026) & (US$ Million) Table 155. Global Pharmaceutical API and Intermediates Production Value Share by Region (2021-2026) Table 156. Global Pharmaceutical API and Intermediates Production Value by Region (2027-2032) & (US$ Million) Table 157. Global Pharmaceutical API and Intermediates Production Value Share by Region: (2027-2032) & (US$ Million) Table 158. Global Pharmaceutical API and Intermediates Market Average Price (US$/Ton) by Region (2021-2026) Table 159. Global Pharmaceutical API and Intermediates Market Average Price (US$/Ton) by Region (2027-2032) Table 160. Global Pharmaceutical API and Intermediates Consumption by Region: 2021 VS 2025 VS 2032 (Tons) Table 161. Global Pharmaceutical API and Intermediates Consumption by Region (2021-2026) & (Tons) Table 162. Global Pharmaceutical API and Intermediates Consumption Market Share by Region (2021-2026) Table 163. Global Pharmaceutical API and Intermediates Consumption Forecasted by Region (2027-2032) & (Tons) Table 164. Global Pharmaceutical API and Intermediates Consumption Forecasted Market Share by Region (2027-2032) Table 165. North America Pharmaceutical API and Intermediates Consumption Growth Rate by Country: 2021 VS 2025 VS 2032 (Tons) Table 166. North America Pharmaceutical API and Intermediates Consumption by Country (2021-2026) & (Tons) Table 167. North America Pharmaceutical API and Intermediates Consumption by Country (2027-2032) & (Tons) Table 168. Europe Pharmaceutical API and Intermediates Consumption Growth Rate by Country: 2021 VS 2025 VS 2032 (Tons) Table 169. Europe Pharmaceutical API and Intermediates Consumption by Country (2021-2026) & (Tons) Table 170. Europe Pharmaceutical API and Intermediates Consumption by Country (2027-2032) & (Tons) Table 171. Asia Pacific Pharmaceutical API and Intermediates Consumption Growth Rate by Country: 2021 VS 2025 VS 2032 (Tons) Table 172. Asia Pacific Pharmaceutical API and Intermediates Consumption by Country (2021-2026) & (Tons) Table 173. Asia Pacific Pharmaceutical API and Intermediates Consumption by Country (2027-2032) & (Tons) Table 174. South America Pharmaceutical API and Intermediates Consumption Growth Rate by Country: 2021 VS 2025 VS 2032 (Tons) Table 175. South America Pharmaceutical API and Intermediates Consumption by Country (2021-2026) & (Tons) Table 176. South America Pharmaceutical API and Intermediates Consumption by Country (2027-2032) & (Tons) Table 177. Middle East & Africa Pharmaceutical API and Intermediates Consumption Growth Rate by Country: 2021 VS 2025 VS 2032 (Tons) Table 178. Middle East & Africa Pharmaceutical API and Intermediates Consumption by Country (2021-2026) & (Tons) Table 179. Middle East & Africa Pharmaceutical API and Intermediates Consumption by Country (2027-2032) & (Tons) Table 180. Key Raw Materials Table 181. Raw Materials Key Suppliers Table 182. Pharmaceutical API and Intermediates Distributors List Table 183. Pharmaceutical API and Intermediates Customers List Table 184. Research Programs/Design for This Report Table 185. Authors List of This Report Table 186. Secondary Sources Table 187. Primary Sources List of Figures Figure 1. Pharmaceutical API and Intermediates Product Image Figure 2. Global Pharmaceutical API and Intermediates Production Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Pharmaceutical API and Intermediates Production Value (2021-2032) & (US$ Million) Figure 4. Global Pharmaceutical API and Intermediates Production Capacity (2021-2032) & (Tons) Figure 5. Global Pharmaceutical API and Intermediates Production (2021-2032) & (Tons) Figure 6. Global Pharmaceutical API and Intermediates Average Price (US$/Ton) & (2021-2032) Figure 7. Global Top 5 and 10 Pharmaceutical API and Intermediates Players Market Share by Production Value in 2025 Figure 8. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. API Image Figure 10. Pharmaceutical Intermediates Image Figure 11. Global Pharmaceutical API and Intermediates Production by Type (2021 VS 2025 VS 2032) & (Tons) Figure 12. Global Pharmaceutical API and Intermediates Production Market Share 2021 VS 2025 VS 2032 Figure 13. Global Pharmaceutical API and Intermediates Production Market Share by Type (2021-2032) Figure 14. Global Pharmaceutical API and Intermediates Production Value by Type (2021 VS 2025 VS 2032) & (Tons) Figure 15. Global Pharmaceutical API and Intermediates Production Value Share 2021 VS 2025 VS 2032 Figure 16. Global Pharmaceutical API and Intermediates Production Value Share by Type (2021-2032) Figure 17. Pharmaceutical Image Figure 18. Feed Image Figure 19. Food Image Figure 20. Cosmetics Image Figure 21. Health Products Image Figure 22. Global Pharmaceutical API and Intermediates Production by Application (2021 VS 2025 VS 2032) & (Tons) Figure 23. Global Pharmaceutical API and Intermediates Production Market Share 2021 VS 2025 VS 2032 Figure 24. Global Pharmaceutical API and Intermediates Production Market Share by Application (2021-2032) Figure 25. Global Pharmaceutical API and Intermediates Production Value by Application (2021 VS 2025 VS 2032) & (Tons) Figure 26. Global Pharmaceutical API and Intermediates Production Value Share 2021 VS 2025 VS 2032 Figure 27. Global Pharmaceutical API and Intermediates Production Value Share by Application (2021-2032) Figure 28. Global Pharmaceutical API and Intermediates Production by Region: 2021 VS 2025 VS 2032 (Tons) Figure 29. Global Pharmaceutical API and Intermediates Production Market Share by Region: 2021 VS 2025 VS 2032 Figure 30. Global Pharmaceutical API and Intermediates Production Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 31. Global Pharmaceutical API and Intermediates Production Value Share by Region: 2021 VS 2025 VS 2032 Figure 32. North America Pharmaceutical API and Intermediates Production Value (2021-2032) & (US$ Million) Figure 33. Europe Pharmaceutical API and Intermediates Production Value (2021-2032) & (US$ Million) Figure 34. Asia-Pacific Pharmaceutical API and Intermediates Production Value (2021-2032) & (US$ Million) Figure 35. South America Pharmaceutical API and Intermediates Production Value (2021-2032) & (US$ Million) Figure 36. Middle East & Africa Pharmaceutical API and Intermediates Production Value (2021-2032) & (US$ Million) Figure 37. North America Pharmaceutical API and Intermediates Consumption and Growth Rate (2021-2032) & (Tons) Figure 38. North America Pharmaceutical API and Intermediates Consumption Market Share by Country (2021-2032) Figure 39. U.S. Pharmaceutical API and Intermediates Consumption and Growth Rate (2021-2032) & (Tons) Figure 40. Canada Pharmaceutical API and Intermediates Consumption and Growth Rate (2021-2032) & (Tons) Figure 41. Mexico Pharmaceutical API and Intermediates Consumption and Growth Rate (2021-2032) & (Tons) Figure 42. Europe Pharmaceutical API and Intermediates Consumption and Growth Rate (2021-2032) & (Tons) Figure 43. Europe Pharmaceutical API and Intermediates Consumption Market Share by Country (2021-2032) Figure 44. Germany Pharmaceutical API and Intermediates Consumption and Growth Rate (2021-2032) & (Tons) Figure 45. France Pharmaceutical API and Intermediates Consumption and Growth Rate (2021-2032) & (Tons) Figure 46. U.K. Pharmaceutical API and Intermediates Consumption and Growth Rate (2021-2032) & (Tons) Figure 47. Italy Pharmaceutical API and Intermediates Consumption and Growth Rate (2021-2032) & (Tons) Figure 48. Netherlands Pharmaceutical API and Intermediates Consumption and Growth Rate (2021-2032) & (Tons) Figure 49. Asia Pacific Pharmaceutical API and Intermediates Consumption and Growth Rate (2021-2032) & (Tons) Figure 50. Asia Pacific Pharmaceutical API and Intermediates Consumption Market Share by Country (2021-2032) Figure 51. China Pharmaceutical API and Intermediates Consumption and Growth Rate (2021-2032) & (Tons) Figure 52. Japan Pharmaceutical API and Intermediates Consumption and Growth Rate (2021-2032) & (Tons) Figure 53. South Korea Pharmaceutical API and Intermediates Consumption and Growth Rate (2021-2032) & (Tons) Figure 54. Southeast Asia Pharmaceutical API and Intermediates Consumption and Growth Rate (2021-2032) & (Tons) Figure 55. India Pharmaceutical API and Intermediates Consumption and Growth Rate (2021-2032) & (Tons) Figure 56. Australia Pharmaceutical API and Intermediates Consumption and Growth Rate (2021-2032) & (Tons) Figure 57. South America Pharmaceutical API and Intermediates Consumption and Growth Rate (2021-2032) & (Tons) Figure 58. South America Pharmaceutical API and Intermediates Consumption Market Share by Country (2021-2032) Figure 59. Brazil Pharmaceutical API and Intermediates Consumption and Growth Rate (2021-2032) & (Tons) Figure 60. Argentina Pharmaceutical API and Intermediates Consumption and Growth Rate (2021-2032) & (Tons) Figure 61. Chile Pharmaceutical API and Intermediates Consumption and Growth Rate (2021-2032) & (Tons) Figure 62. Middle East & Africa Pharmaceutical API and Intermediates Consumption and Growth Rate (2021-2032) & (Tons) Figure 63. Middle East & Africa Pharmaceutical API and Intermediates Consumption Market Share by Country (2021-2032) Figure 64. Egypt Pharmaceutical API and Intermediates Consumption and Growth Rate (2021-2032) & (Tons) Figure 65. South Africa Pharmaceutical API and Intermediates Consumption and Growth Rate (2021-2032) & (Tons) Figure 66. Israel Pharmaceutical API and Intermediates Consumption and Growth Rate (2021-2032) & (Tons) Figure 67. Türkiye Pharmaceutical API and Intermediates Consumption and Growth Rate (2021-2032) & (Tons) Figure 68. GCC Countries Pharmaceutical API and Intermediates Consumption and Growth Rate (2021-2032) & (Tons) Figure 69. Pharmaceutical API and Intermediates Value Chain Figure 70. Manufacturing Cost Structure Figure 71. Pharmaceutical API and Intermediates Production Mode & Process Figure 72. Direct Comparison with Distribution Share Figure 73. Distributors Profiles Figure 74. Years Considered Figure 75. Research Process Figure 76. Key Executives Interviewed

Scope & coverage.

Types
  • API
  • Pharmaceutical Intermediates
Applications
  • Pharmaceutical
  • Feed
  • Food
  • Cosmetics
  • Health Products
Companies covered
  • Lonza
  • BASF
  • Patheon
  • Lianhetech
  • Jubilant
  • Catalent
  • ABA Chem
  • Actylis
  • Chiracon
  • Codexis
  • CordenPharma
  • Granules India
  • Pfizer
  • Porton
  • Sanofi
  • Jiuzhou Pharmaceutical
  • Menohua
  • Puluo Pharmaceutical
  • Stanley
  • Tianyu shares
  • Huahai Pharmaceutical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Pharmaceutical API and Intermediates Production Value Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Pharmaceutical API and Intermediates Production Capacity Estimates and Forecasts (2021-2032)
  5. 1.2.3 Global Pharmaceutical API and Intermediates Production Estimates and Forecasts (2021-2032)
  6. 1.2.4 Global Pharmaceutical API and Intermediates Market Average Price (2021-2032)
  7. 1.3 Assumptions and Limitations
  8. 1.4 Study Goals and Objectives
2 Global Pharmaceutical API and Intermediates Market Dynamics
  1. 2.1 Pharmaceutical API and Intermediates Industry Trends
  2. 2.2 Pharmaceutical API and Intermediates Industry Drivers
  3. 2.3 Pharmaceutical API and Intermediates Industry Opportunities and Challenges
  4. 2.4 Pharmaceutical API and Intermediates Industry Restraints
3 Pharmaceutical API and Intermediates Market by Manufacturers
  1. 3.1 Global Pharmaceutical API and Intermediates Production Value by Manufacturers (2021-2026)
  2. 3.2 Global Pharmaceutical API and Intermediates Production by Manufacturers (2021-2026)
  3. 3.3 Global Pharmaceutical API and Intermediates Average Price by Manufacturers (2021-2026)
  4. 3.4 Global Pharmaceutical API and Intermediates Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Pharmaceutical API and Intermediates Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Pharmaceutical API and Intermediates Manufacturers, Product Type & Application
  7. 3.7 Global Pharmaceutical API and Intermediates Manufacturers Established Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Pharmaceutical API and Intermediates Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Pharmaceutical API and Intermediates Players Market Share by Production Value in 2025
  11. 3.8.3 2025 Pharmaceutical API and Intermediates Tier 1, Tier 2, and Tier 3
4 Pharmaceutical API and Intermediates Market by Type
  1. 4.1 Pharmaceutical API and Intermediates Type Introduction
  2. 4.1.1 API
  3. 4.1.2 Pharmaceutical Intermediates
  4. 4.2 Global Pharmaceutical API and Intermediates Production by Type
  5. 4.2.1 Global Pharmaceutical API and Intermediates Production by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Pharmaceutical API and Intermediates Production by Type (2021-2032)
  7. 4.2.3 Global Pharmaceutical API and Intermediates Production Market Share by Type (2021-2032)
  8. 4.3 Global Pharmaceutical API and Intermediates Production Value by Type
  9. 4.3.1 Global Pharmaceutical API and Intermediates Production Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Pharmaceutical API and Intermediates Production Value by Type (2021-2032)
  11. 4.3.3 Global Pharmaceutical API and Intermediates Production Value Market Share by Type (2021-2032)
5 Pharmaceutical API and Intermediates Market by Application
  1. 5.1 Pharmaceutical API and Intermediates Application Introduction
  2. 5.1.1 Pharmaceutical
  3. 5.1.2 Feed
  4. 5.1.3 Food
  5. 5.1.4 Cosmetics
  6. 5.1.5 Health Products
  7. 5.2 Global Pharmaceutical API and Intermediates Production by Application
  8. 5.2.1 Global Pharmaceutical API and Intermediates Production by Application (2021 VS 2025 VS 2032)
  9. 5.2.2 Global Pharmaceutical API and Intermediates Production by Application (2021-2032)
  10. 5.2.3 Global Pharmaceutical API and Intermediates Production Market Share by Application (2021-2032)
  11. 5.3 Global Pharmaceutical API and Intermediates Production Value by Application
  12. 5.3.1 Global Pharmaceutical API and Intermediates Production Value by Application (2021 VS 2025 VS 2032)
  13. 5.3.2 Global Pharmaceutical API and Intermediates Production Value by Application (2021-2032)
  14. 5.3.3 Global Pharmaceutical API and Intermediates Production Value Market Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Lonza
  2. 6.1.1 Lonza Company Information
  3. 6.1.2 Lonza Business Overview
  4. 6.1.3 Lonza Pharmaceutical API and Intermediates Production, Value and Gross Margin (2021-2026)
  5. 6.1.4 Lonza Pharmaceutical API and Intermediates Product Portfolio
  6. 6.1.5 Lonza Recent Developments
  7. 6.2 BASF
  8. 6.2.1 BASF Company Information
  9. 6.2.2 BASF Business Overview
  10. 6.2.3 BASF Pharmaceutical API and Intermediates Production, Value and Gross Margin (2021-2026)
  11. 6.2.4 BASF Pharmaceutical API and Intermediates Product Portfolio
  12. 6.2.5 BASF Recent Developments
  13. 6.3 Patheon
  14. 6.3.1 Patheon Company Information
  15. 6.3.2 Patheon Business Overview
  16. 6.3.3 Patheon Pharmaceutical API and Intermediates Production, Value and Gross Margin (2021-2026)
  17. 6.3.4 Patheon Pharmaceutical API and Intermediates Product Portfolio
  18. 6.3.5 Patheon Recent Developments
  19. 6.4 Lianhetech
  20. 6.4.1 Lianhetech Company Information
  21. 6.4.2 Lianhetech Business Overview
  22. 6.4.3 Lianhetech Pharmaceutical API and Intermediates Production, Value and Gross Margin (2021-2026)
  23. 6.4.4 Lianhetech Pharmaceutical API and Intermediates Product Portfolio
  24. 6.4.5 Lianhetech Recent Developments
  25. 6.5 Jubilant
  26. 6.5.1 Jubilant Company Information
  27. 6.5.2 Jubilant Business Overview
  28. 6.5.3 Jubilant Pharmaceutical API and Intermediates Production, Value and Gross Margin (2021-2026)
  29. 6.5.4 Jubilant Pharmaceutical API and Intermediates Product Portfolio
  30. 6.5.5 Jubilant Recent Developments
  31. 6.6 Catalent
  32. 6.6.1 Catalent Company Information
  33. 6.6.2 Catalent Business Overview
  34. 6.6.3 Catalent Pharmaceutical API and Intermediates Production, Value and Gross Margin (2021-2026)
  35. 6.6.4 Catalent Pharmaceutical API and Intermediates Product Portfolio
  36. 6.6.5 Catalent Recent Developments
  37. 6.7 ABA Chem
  38. 6.7.1 ABA Chem Company Information
  39. 6.7.2 ABA Chem Business Overview
  40. 6.7.3 ABA Chem Pharmaceutical API and Intermediates Production, Value and Gross Margin (2021-2026)
  41. 6.7.4 ABA Chem Pharmaceutical API and Intermediates Product Portfolio
  42. 6.7.5 ABA Chem Recent Developments
  43. 6.8 Actylis
  44. 6.8.1 Actylis Company Information
  45. 6.8.2 Actylis Business Overview
  46. 6.8.3 Actylis Pharmaceutical API and Intermediates Production, Value and Gross Margin (2021-2026)
  47. 6.8.4 Actylis Pharmaceutical API and Intermediates Product Portfolio
  48. 6.8.5 Actylis Recent Developments
  49. 6.9 Chiracon
  50. 6.9.1 Chiracon Company Information
  51. 6.9.2 Chiracon Business Overview
  52. 6.9.3 Chiracon Pharmaceutical API and Intermediates Production, Value and Gross Margin (2021-2026)
  53. 6.9.4 Chiracon Pharmaceutical API and Intermediates Product Portfolio
  54. 6.9.5 Chiracon Recent Developments
  55. 6.10 Codexis
  56. 6.10.1 Codexis Company Information
  57. 6.10.2 Codexis Business Overview
  58. 6.10.3 Codexis Pharmaceutical API and Intermediates Production, Value and Gross Margin (2021-2026)
  59. 6.10.4 Codexis Pharmaceutical API and Intermediates Product Portfolio
  60. 6.10.5 Codexis Recent Developments
  61. 6.11 CordenPharma
  62. 6.11.1 CordenPharma Company Information
  63. 6.11.2 CordenPharma Business Overview
  64. 6.11.3 CordenPharma Pharmaceutical API and Intermediates Production, Value and Gross Margin (2021-2026)
  65. 6.11.4 CordenPharma Pharmaceutical API and Intermediates Product Portfolio
  66. 6.11.5 CordenPharma Recent Developments
  67. 6.12 Granules India
  68. 6.12.1 Granules India Company Information
  69. 6.12.2 Granules India Business Overview
  70. 6.12.3 Granules India Pharmaceutical API and Intermediates Production, Value and Gross Margin (2021-2026)
  71. 6.12.4 Granules India Pharmaceutical API and Intermediates Product Portfolio
  72. 6.12.5 Granules India Recent Developments
  73. 6.13 Pfizer
  74. 6.13.1 Pfizer Company Information
  75. 6.13.2 Pfizer Business Overview
  76. 6.13.3 Pfizer Pharmaceutical API and Intermediates Production, Value and Gross Margin (2021-2026)
  77. 6.13.4 Pfizer Pharmaceutical API and Intermediates Product Portfolio
  78. 6.13.5 Pfizer Recent Developments
  79. 6.14 Porton
  80. 6.14.1 Porton Company Information
  81. 6.14.2 Porton Business Overview
  82. 6.14.3 Porton Pharmaceutical API and Intermediates Production, Value and Gross Margin (2021-2026)
  83. 6.14.4 Porton Pharmaceutical API and Intermediates Product Portfolio
  84. 6.14.5 Porton Recent Developments
  85. 6.15 Sanofi
  86. 6.15.1 Sanofi Company Information
  87. 6.15.2 Sanofi Business Overview
  88. 6.15.3 Sanofi Pharmaceutical API and Intermediates Production, Value and Gross Margin (2021-2026)
  89. 6.15.4 Sanofi Pharmaceutical API and Intermediates Product Portfolio
  90. 6.15.5 Sanofi Recent Developments
  91. 6.16 Jiuzhou Pharmaceutical
  92. 6.16.1 Jiuzhou Pharmaceutical Company Information
  93. 6.16.2 Jiuzhou Pharmaceutical Business Overview
  94. 6.16.3 Jiuzhou Pharmaceutical Pharmaceutical API and Intermediates Production, Value and Gross Margin (2021-2026)
  95. 6.16.4 Jiuzhou Pharmaceutical Pharmaceutical API and Intermediates Product Portfolio
  96. 6.16.5 Jiuzhou Pharmaceutical Recent Developments
  97. 6.17 Menohua
  98. 6.17.1 Menohua Company Information
  99. 6.17.2 Menohua Business Overview
  100. 6.17.3 Menohua Pharmaceutical API and Intermediates Production, Value and Gross Margin (2021-2026)
  101. 6.17.4 Menohua Pharmaceutical API and Intermediates Product Portfolio
  102. 6.17.5 Menohua Recent Developments
  103. 6.18 Puluo Pharmaceutical
  104. 6.18.1 Puluo Pharmaceutical Company Information
  105. 6.18.2 Puluo Pharmaceutical Business Overview
  106. 6.18.3 Puluo Pharmaceutical Pharmaceutical API and Intermediates Production, Value and Gross Margin (2021-2026)
  107. 6.18.4 Puluo Pharmaceutical Pharmaceutical API and Intermediates Product Portfolio
  108. 6.18.5 Puluo Pharmaceutical Recent Developments
  109. 6.19 Stanley
  110. 6.19.1 Stanley Company Information
  111. 6.19.2 Stanley Business Overview
  112. 6.19.3 Stanley Pharmaceutical API and Intermediates Production, Value and Gross Margin (2021-2026)
  113. 6.19.4 Stanley Pharmaceutical API and Intermediates Product Portfolio
  114. 6.19.5 Stanley Recent Developments
  115. 6.20 Tianyu shares
  116. 6.20.1 Tianyu shares Company Information
  117. 6.20.2 Tianyu shares Business Overview
  118. 6.20.3 Tianyu shares Pharmaceutical API and Intermediates Production, Value and Gross Margin (2021-2026)
  119. 6.20.4 Tianyu shares Pharmaceutical API and Intermediates Product Portfolio
  120. 6.20.5 Tianyu shares Recent Developments
  121. 6.21 Huahai Pharmaceutical
  122. 6.21.1 Huahai Pharmaceutical Company Information
  123. 6.21.2 Huahai Pharmaceutical Business Overview
  124. 6.21.3 Huahai Pharmaceutical Pharmaceutical API and Intermediates Production, Value and Gross Margin (2021-2026)
  125. 6.21.4 Huahai Pharmaceutical Pharmaceutical API and Intermediates Product Portfolio
  126. 6.21.5 Huahai Pharmaceutical Recent Developments
7 Global Pharmaceutical API and Intermediates Production by Region
  1. 7.1 Global Pharmaceutical API and Intermediates Production by Region: 2021 VS 2025 VS 2032
  2. 7.2 Global Pharmaceutical API and Intermediates Production by Region (2021-2032)
  3. 7.2.1 Global Pharmaceutical API and Intermediates Production by Region (2021-2026)
  4. 7.2.2 Global Pharmaceutical API and Intermediates Production Forecast by Region (2027-2032)
  5. 7.3 Global Pharmaceutical API and Intermediates Production by Region: 2021 VS 2025 VS 2032
  6. 7.4 Global Pharmaceutical API and Intermediates Production Value by Region (2021-2032)
  7. 7.4.1 Global Pharmaceutical API and Intermediates Production Value by Region (2021-2026)
  8. 7.4.2 Global Pharmaceutical API and Intermediates Production Value by Region (2027-2032)
  9. 7.5 Global Pharmaceutical API and Intermediates Market Price Analysis by Region (2021-2032)
  10. 7.6 Regional Production Value Trends (2021-2032)
  11. 7.6.1 North America Pharmaceutical API and Intermediates Production Value (2021-2032)
  12. 7.6.2 Europe Pharmaceutical API and Intermediates Production Value (2021-2032)
  13. 7.6.3 Asia-Pacific Pharmaceutical API and Intermediates Production Value (2021-2032)
  14. 7.6.4 South America Pharmaceutical API and Intermediates Production Value (2021-2032)
  15. 7.6.5 Middle East & Africa Pharmaceutical API and Intermediates Production Value (2021-2032)
8 Global Pharmaceutical API and Intermediates Consumption by Region
  1. 8.1 Global Pharmaceutical API and Intermediates Consumption by Region: 2021 VS 2025 VS 2032
  2. 8.2 Global Pharmaceutical API and Intermediates Consumption by Region (2021-2032)
  3. 8.2.1 Global Pharmaceutical API and Intermediates Consumption by Region (2021-2026)
  4. 8.2.2 Global Pharmaceutical API and Intermediates Consumption by Region (2027-2032)
  5. 8.3 North America
  6. 8.3.1 North America Pharmaceutical API and Intermediates Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 8.3.2 North America Pharmaceutical API and Intermediates Consumption by Country (2021-2032)
  8. 8.3.3 U.S.
  9. 8.3.4 Canada
  10. 8.3.5 Mexico
  11. 8.4 Europe
  12. 8.4.1 Europe Pharmaceutical API and Intermediates Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 8.4.2 Europe Pharmaceutical API and Intermediates Consumption by Country (2021-2032)
  14. 8.4.3 Germany
  15. 8.4.4 France
  16. 8.4.5 U.K.
  17. 8.4.6 Italy
  18. 8.4.7 Netherlands
  19. 8.5 Asia Pacific
  20. 8.5.1 Asia Pacific Pharmaceutical API and Intermediates Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 8.5.2 Asia Pacific Pharmaceutical API and Intermediates Consumption by Country (2021-2032)
  22. 8.5.3 China
  23. 8.5.4 Japan
  24. 8.5.5 South Korea
  25. 8.5.6 Southeast Asia
  26. 8.5.7 India
  27. 8.5.8 Australia
  28. 8.6 South America
  29. 8.6.1 South America Pharmaceutical API and Intermediates Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 8.6.2 South America Pharmaceutical API and Intermediates Consumption by Country (2021-2032)
  31. 8.6.3 Brazil
  32. 8.6.4 Argentina
  33. 8.6.5 Chile
  34. 8.6.6 Colombia
  35. 8.7 Middle East & Africa
  36. 8.7.1 Middle East & Africa Pharmaceutical API and Intermediates Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
  37. 8.7.2 Middle East & Africa Pharmaceutical API and Intermediates Consumption by Country (2021-2032)
  38. 8.7.3 Egypt
  39. 8.7.4 South Africa
  40. 8.7.5 Israel
  41. 8.7.6 Türkiye
  42. 8.7.7 GCC Countries
9 Value Chain and Sales Channels Analysis
  1. 9.1 Pharmaceutical API and Intermediates Value Chain Analysis
  2. 9.1.1 Pharmaceutical API and Intermediates Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Pharmaceutical API and Intermediates Production Mode & Process
  6. 9.2 Pharmaceutical API and Intermediates Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Pharmaceutical API and Intermediates Distributors
  9. 9.2.3 Pharmaceutical API and Intermediates Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst